Multimedia

Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class...

Steven Feldman, MD, PhD, Wake Forest University School of Medicine, discusses the real-world effectiveness of dupilumab for the treatment of atopic dermatitis, how this data is relevant for payers, and stresses the importance of studying...

Edmund Pezalla, MD, MPH, CEO, Enlightenment Bioconsult LLC, discusses treatment options for multiple sclerosis, highlights results from the ASCLEPIOS I and II studies, and notes why this data can be useful for payers.

Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology at The George Washington University School of Medicine and Health Sciences, Washington, DC, offers insight into his real-world data study in which he and his colleagues...

Lakiea Wright, MD, explains how health care professionals can identify allergic asthma triggers in the age of social distancing and highlights factors that should be considered when differentiating between COVID-19 and general allergy...

Brett Zelkind, senior vice president of business development and Eric Zerneke, chief commercial officer, both at CredSimple, explain why social determinants of health and the uptake in telehealth should be considered throughout the navigation...

Deepak L. Bhatt MD, MPH, FACC, FAHA, FSCAI, FESC, executive director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital Heart & Vascular Center and professor of Medicine at Harvard Medical School, discusses the benefits...

Gupreet Singh, Health Services Leader at PwC Health Research Institute, discusses a recent survey that examined how the current pandemic has influenced the health and behavior of consumers such as medication spending and how the cost of...

Raymond Comenzo, MD, hematologist, reviews the findings of the phase III ANDROMEDA trial and details how the addition of daratumumab improves hematologic responses and clinical outcomes.

Keith Pratz, MD, associate professor of medicine at the Abramson Comprehensive Cancer Center at University of Pennsylvania, discusses the phase III VIALE-A study that demonstrated a reduction in the risk of death in patients with AML among...